Healthcare & Life Sciences
Tessera Therapeutics
Cambridge, United Stateswww.tesseratherapeutics.com/
Tessera Therapeutics is a series c plus startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2020
Founded
1
Investors
About Tessera Therapeutics
Based in Cambridge, the United States, Tessera Therapeutics is a startup founded in 2020. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Tessera Therapeutics develops Gene Writing™, a genome-engineering platform enabling permanent therapeutic modifications to the human genome, and proprietary non-viral delivery systems to target genetic diseases.
Explore Tessera Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.